🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Multicenter Prospective Cohort Study of Twin Maternal-Child Dyads in China

Recruitingn/aAges 18 Years - 45 YearsFemalePeking University Third Hospital
NCT06414655 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Multicenter Prospective Cohort Study of Twin Maternal-Child Dyads in China (ChiTwiMC) is supported by National Key Research and Development Program of China - Reproductive Health and Women's and Children's Health Protection Project. This project is funded by the Ministry of Science and Technology of China under grant number 2023YFC2705900. The ChiTwiMC cohort is led by Professor Wei Yuan from the Department of Gynecology and Obstetrics at Peking University Third Hospital.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Twin pregnancies * Female aged between 18-45 years * Gestational age is less than 14 weeks * Planning to receive prenatal healthcare and delivery service at the study hospital * Signing informed concent and willing to participate Exclusion Criteria: * Women with mental disorders or serious maternal illness that is not eligible to participate * Inability to provide informed consent * Pregnant women not registered in our hospital
💊

What it tests

  • Not listed
📍

Where

11 sites
The First Affiliated Hospital of Anhui Medical University
Hefei, China
Peking University Third Hospital
Beijing, China
Peking University
Beijing, China
Chongqing Medical University
Chongqing, China
First Affiliated Hospital, Sun Yat-Sen University
Guangzhou, China
Shengjing Hospital
Shenyang, China
Shandong Provincial Hospital
Jinan, China
The Second Hospital of Shandong University
Jinan, China

…and 3 more on ClinicalTrials.gov.

🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy